

Compounded Tirzepatide
Tirzepatide (compounded)
Compounded · not FDA-approved· 503A Partner PharmacyProvider-prescribed, pharmacy-compounded tirzepatide at a cash-pay price.
Starting at $219/mo
$349
after provider approval
Compounded · not FDA-approvedStart intakeNo charge until a licensed provider approves your treatment.
Reviewed by US-licensed providers
Free, discreet shipping
This treatment requires a licensed provider review. Start your intake instead.
What to expect
Day 0
Intake
A short online medical questionnaire, reviewed against your history.
Day 1–2
Provider review
A US-licensed provider reviews and messages you with any questions.
Day 2–4
Pharmacy ships
If approved, a licensed US pharmacy fills and ships your order.
Day 4–7
Arrives
Discreet, tracked delivery. Follow-up care is included.
Timelines are estimates and depend on provider review and pharmacy fulfillment. No medication is dispensed without a valid prescription.
Clinical notes
Dual GIP/GLP-1 activity. Compounded formulation is not FDA-approved; concentration and dosing schedule are set by your provider and pharmacy.
Regulatory notice
This is a compounded medication prepared by a state-licensed 503A pharmacy. It is not FDA-approved. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality, and may not be substituted for an FDA-approved product without your provider's guidance.
Prescription products require an online consultation with a licensed provider. Pricing shown is the cash-pay rate if treatment is approved; you will not be charged for medication unless a provider approves it.
Related treatments

Best valueSemaglutide (compounded)
after provider approval
Compounded · not FDA-approved
Bestseller
Bestseller